Auranofin.
Kean
W F
WF
Rheumatic Disease Unit, McMaster University, Hamilton, Ontario, Canada.
Hart
L
L
Buchanan
W W
WW
D000293:Adolescent; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001310:Auranofin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007596:Joints / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D008875:Middle Aged; D011859:Radiography; D016032:Randomized Controlled Trials as Topic; D012216:Rheumatic Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D001310:Auranofin